Skip to content

Assistive Device for Hand Osteoarthritis

Self-care Program Evaluation With Focus on Assistive Devices for Individuals With Hand Osteoarthritis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02667145
Enrollment
39
Registered
2016-01-28
Start date
2014-11-30
Completion date
2016-01-31
Last updated
2016-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hand Osteoarthritis

Keywords

hand osteoarthritis, self care program, assistive tecnology

Brief summary

Randomized clinical trial , blind for evaluators, to assess the effectiveness of a self-care program using assistive technology for treatment of hand osteoarthritis.

Detailed description

This program aims to: * Encourage the use of assistive devices on a daily basis as the main form of joint protection. * Encourage individual motivation, from the group in attendance, behavior change, developing the capacity of self-management of individuals of their health problems. Will be held for 4 meetings with an average duration of 90 minutes. Meeting 1: Its proposal address the importance of self-care in the treatment of chronic diseases; knowing the OA of the hands and their main characteristics; recognize the importance of hand function for carrying out activities; understand the meaning of self-care and joint protection; motivation adherence to the program and behavior change. Meeting 2: Present assistive devices as a protection feature; teach joint protection techniques and energy conservation focusing on the assistive device; deliver and demonstrate the use of assistive devices. Meeting 3:Encouraging the adhesion of the techniques presented; making workshop for daily activities; verify the difficulties with devices use by the volunteers. Meeting 4: Strengthening guidance given in previous meetings; make closing with the group to in connection with the program; motivated to continue carrying out the activities at home.

Interventions

OTHERSelf care program focusing on the assistive device

self-heed program focusing on the assistive device will consist of four weekly meetings lasting approximately 90 minutes. it will be stimulated the self-heed through knowledge of pathology and guidelines of protection articulate, and will be supplied, and trained the use of assistive devices to improve the performance of volunteers in their daily activities. Assistive devices are devices, not attached to the body, which help people with limited movements and restrictions on participation in the activities of everyday life. Example: thickening of tableware, tin openers. These volunteers will be evaluated in three stages: 1-initial assessment 2-after completion of the program and 90 days after the initial assessment. The questionnaires that will be used are: EVA; SACRAH; COPM; WHOQOL-Bref.

Sponsors

Daniela Salgado Amaral
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Hand OA diagnosis according to the criteria of the American College of Rheumatology (ACR ) * Be properly registered in the rheumatology clinic of Hospital das Clínicas

Exclusion criteria

* Surgical treatment or infiltration in the hands, in the last 6 months; * Treatment of occupational therapy and / or physical therapy, or use of any TA feature (assist device or stent) in the last 6 months; * Diagnosis of another rheumatologic disease or musculoskeletal system that compromise the hands associated.

Design outcomes

Primary

MeasureTime frameDescription
Occupational Performance4 weeksinvolvement of daily activities by the Canadian Occupational Performance Measure (COPM)

Secondary

MeasureTime frameDescription
Quality of life4 weeksEvaluation by WHO-QOL bref
Manual functional4 weeksEvoluation by SACRAH
Pain4 weeksEvaluation by visual analogue pain scale

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026